VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DMAC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DMACDiaMedica Therapeutics Inc.
$8.01$432M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDMACPrice History

DMAC logoDiaMedica Therapeutics Inc. (DMAC) Stock Price History

Historical prices from 2012 to 2026

$8.01+0.39  (+5.12%)close Jul 6
Returns
1M
+42.8%
3M
+21.0%
YTD
+1.0%
1Y
+120.7%
3Y
+25.6%
5Y
+15.3%
ATH$44.94Aug 2012-82.2%
ATL$0.81Dec 2014pre-split
Avg Vol (50D)173K/ day
52-Week Range$3.57 — $10.42
LowCurrent: $8.01High

Loading 10-year price history...

DMAC Historical Performance

1 YearTotal Return
+120.7%
Price: +120.7%
3 YearsTotal Return
+98.3%
CAGR: +25.6%
Price: +98.3%
5 YearsTotal Return
+103.8%
CAGR: +15.3%
Price: +103.8%
YTD
+1.0%

DMAC Annual Returns

Year-by-year price performance · 2012–2026

Best+127.3%2017
Worst-93.5%2014
Up years9/15
2012-43.7%
2013-33.5%
2014-93.5%
2015+90.0%
2016+15.8%
2017+127.3%
2018-40.4%
2019+50.2%
2020+108.6%
2021-62.8%
2022-59.3%
2023+91.9%
2024+91.9%
2025+44.5%
2026+0.3%
2012 annual price return
-43.7%
2013 annual price return
-33.5%
2014 annual price return
-93.5%
2015 annual price return
+90.0%
2016 annual price return
+15.8%
2017 annual price return
+127.3%
2018 annual price return
-40.4%
2019 annual price return
+50.2%
2020 annual price return
+108.6%
2021 annual price return
-62.8%
2022 annual price return
-59.3%
2023 annual price return
+91.9%
2024 annual price return
+91.9%
2025 annual price return
+44.5%
2026 annual price return
+0.3%
LessMore
Alpha vs S&P 500
1Y+49.7%
3Y-5.4%
5Y-14.3%

Price returns only.

Download Historical Data

3,499 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

DMAC Stock Price Trajectory (2012–2026)

As of July 6, 2026, DiaMedica Therapeutics Inc. (DMAC) trades at $8.01, representing a +120.7% return over the past year. The stock has delivered a +103.8% total return over five years (+15.3% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $44.94 on August 7, 2012. From this peak, DMAC has corrected -82.2%, currently trading 12% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ATHA (+31.5% 1Y), ACMR (+252.1% 1Y), and NERV (+200.0% 1Y), DMAC has underperformed the peer group average. Compare DMAC vs ATHA →

DMAC Historical Price Data · from 2012

Rows 1–50 of 3,499
Date Open High Low Close Volume Change %
2026-07-067.848.537.848.01477K+5.12%
2026-07-027.427.747.277.62214K+2.42%
2026-07-017.027.496.987.44276K+5.68%
2026-06-307.217.427.017.04284K-2.49%
2026-06-296.697.256.687.22386K+10.23%
2026-06-266.156.756.026.550+6.50%
2026-06-256.476.576.146.15106K-3.30%
2026-06-246.366.716.306.36224K+1.27%
2026-06-235.786.315.786.28206K+6.62%
2026-06-225.776.035.775.89126K+0.68%
2026-06-185.765.875.615.85206K+2.09%
2026-06-175.725.955.635.73176K+0.70%
2026-06-165.785.825.365.69183K+1.07%
2026-06-155.685.845.565.63175K-0.35%
2026-06-125.585.735.385.65104K+3.48%
2026-06-115.325.475.255.46125K+2.44%
2026-06-105.425.645.285.33147K-1.66%
2026-06-095.635.815.305.42347K-3.39%
2026-06-085.685.835.525.61151K-0.53%
2026-06-055.825.875.475.64188K-3.42%
2026-06-045.755.855.655.8493K+3.36%
2026-06-035.725.865.625.65179K-2.08%
2026-06-025.765.895.545.77152K-1.20%
2026-06-015.916.045.755.84178K-2.50%
2026-05-296.086.405.995.99204K-2.76%
2026-05-286.166.256.016.1685K+0.98%
2026-05-276.306.456.076.10132K-3.48%
2026-05-266.016.325.926.32182K+6.94%
2026-05-225.775.965.775.910+2.43%
2026-05-215.605.875.505.77108K+0.87%
2026-05-205.535.765.525.72176K+2.69%
2026-05-195.625.755.555.57144K-1.94%
2026-05-186.056.125.615.68310K-6.27%
2026-05-156.236.266.006.06120K-4.72%
2026-05-146.146.376.136.3695K+1.60%
2026-05-136.216.346.196.26145K-0.95%
2026-05-126.366.466.186.32185K-2.02%
2026-05-116.336.636.266.45115K+2.06%
2026-05-086.426.616.186.32172K-3.22%
2026-05-076.446.535.886.53303K+0.15%
2026-05-066.206.576.066.52168K+4.32%
2026-05-056.136.336.076.25128K+3.31%
2026-05-046.166.405.966.05176K-2.10%
2026-05-016.046.265.816.18191K+2.15%
2026-04-306.106.205.896.05167K+1.51%
2026-04-296.146.195.925.9693K-4.18%
2026-04-286.336.346.226.22103K-1.58%
2026-04-276.286.416.276.3297K-0.16%
2026-04-246.136.356.006.33129K+1.77%
2026-04-236.336.466.166.22114K-3.86%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DMAC — Frequently Asked Questions

Quick answers to the most common questions about buying DMAC stock.

How has DMAC stock performed recently?

DMAC returned +120.7% over the past year, beating its 5-year annualized CAGR of +15.3%. The stock trades above its 200-day moving average, confirming the uptrend.

What is DMAC's all-time high price?

DiaMedica Therapeutics Inc. reached $44.94 on 2012-08-07. The 52-week high is $10.42. Current 1-year return of +120.7% places the stock closer to historical peaks.

Where can I download DMAC historical price data?

This page provides DMAC daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.

501 data points · sampled from 3,499